Antitumor Effect of Brusatol in Acute Lymphoblastic Leukemia Models Is Triggered by Reactive Oxygen Species Accumulation
Open Access
- 6 September 2022
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 10 (9) , 2207
Abstract
Acute lymphoblastic leukemia (ALL) is one of the most common hematological malignancies at pediatric ages and is characterized by different chromosomal rearrangements and genetic abnormalities involved in the differentiation and proliferation of lymphoid precursor cells. Brusatol is a quassinoid plant extract extensively studied due to its antineoplastic effect through global protein synthesis and nuclear factor erythroid 2-related factor-2 (NRF2) signaling inhibition. NRF2 is the main regulator of cellular antioxidant response and reactive oxygen species (ROS), which plays an important role in oxidative stress regulation. This study aimed to evaluate the effect of brusatol in in vitro models of ALL. KOPN-8 (B-ALL), CEM (T-ALL), and MOLT-4 (T-ALL) cell lines were incubated with increasing concentrations of brusatol, and the metabolic activity was evaluated using the resazurin assay. Flow cytometry was used to evaluate cell death, cell cycle, mitochondrial membrane potential (Δψmit), and to measure ROS and reduced glutathione (GSH) levels. Our results show that brusatol promoted a decrease in metabolic activity in ALL cell lines in a time-, dose-, and cell-line-dependent manner. Brusatol induced a cytostatic effect by cell cycle arrest in G0/G1 in all cell lines; however, cell death mediated by apoptosis was only observed in T-ALL cells. Brusatol leads to an oxidative stress imbalance by the increase in ROS levels, namely, superoxide anion. Redox imbalance and cellular apoptosis induced by brusatol are highly modulated by mitochondria disruption as a decrease in mitochondrial membrane potential is detected. These data suggest that brusatol might represent a new therapeutic approach for acute lymphoblastic leukemia, particularly for ALL T-cell lineage.Keywords
Funding Information
- Fundação para a Ciência e a Tecnologia (UID/NEU/04539/2013, UID/NEU/04539/2019)
- Fundação para a Ciência e a Tecnologia (POCI-01-0145-FEDER-007440)
- Fundação para a Ciência e a Tecnologia (SFRH/BD/145531/2019)
This publication has 43 references indexed in Scilit:
- Brusatol Enhances the Radiosensitivity of A549 Cells by Promoting ROS Production and Enhancing DNA DamageInternational Journal of Molecular Sciences, 2016
- Application of Mass Spectrometry Profiling to Establish Brusatol as an Inhibitor of Global Protein SynthesisMolecular & Cellular Proteomics, 2016
- Acute Lymphoblastic Leukemia in ChildrenNew England Journal of Medicine, 2015
- Oxidative stress and mitochondrial dysfunction play a role in myelodysplastic syndrome development, diagnosis, and prognosis: A pilot studyFree Radical Research, 2015
- A possible role for oxidation stress in lymphoid leukaemias and therapeutic failureLeukemia Research, 2012
- Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology GroupJournal of Clinical Oncology, 2012
- Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology GroupBlood, 2011
- Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanismProceedings of the National Academy of Sciences, 2011
- Dynamic association of MLL1, H3K4 trimethylation with chromatin and Hox gene expression during the cell cycleThe FEBS Journal, 2009
- Brusatol-mediated induction of leukemic cell differentiation and G1 arrest is associated with down-regulation of c-mycLeukemia, 2002